TY - JOUR
T1 - Coronavirus Pandemic Anxiety Scale (CPAS-11)
T2 - development and initial validation
AU - Bernardo, Allan B.I.
AU - Mendoza, Norman B.
AU - Simon, Patricia D.
AU - Cunanan, Angela Lorraine P.
AU - Dizon, John Ian Wilzon T.
AU - Tarroja, Maria Caridad H.
AU - Ma. Balajadia-Alcala, Araceli
AU - Saplala, Jesus Enrique G.
N1 - This work was supported by Research Fellowship Grant to the first author given by the National Academy of Science and Technology, Department of Science and Technology, Republic of the Philippines.
Publisher Copyright:
© Springer Science+Business Media, LLC, part of Springer Nature 2020
PY - 2022/8
Y1 - 2022/8
N2 - The mental health impact of the COVID-19 pandemic will increase as the outbreak continues and persist even after the pandemic passes. We developed an 11-item Coronavirus Pandemic Anxiety Scale (CPAS-11) to measure symptoms of anxiety related to the COVID-19 pandemic to help identify individuals who might need mental health services. In developing the scale items, we considered previous research and theory on anxiety symptoms and symptoms reported by clinically referred cases in the Philippines. The scale was validated in a Filipino sample (N = 925). Exploratory factor analysis indicated two factors corresponding to somatic and non-somatic symptoms; confirmatory factor analysis showed good fit for the two-factor model. CPAS-11 showed good internal consistency, convergent and divergent validity, and screening accuracy. A cutoff score of 15 showed adequate sensitivity and specificity to distinguish GAD-7 screened participants. The results support the viability of CPAS-11 as a screening tool to identify individuals experiencing COVID-19-related anxiety.
AB - The mental health impact of the COVID-19 pandemic will increase as the outbreak continues and persist even after the pandemic passes. We developed an 11-item Coronavirus Pandemic Anxiety Scale (CPAS-11) to measure symptoms of anxiety related to the COVID-19 pandemic to help identify individuals who might need mental health services. In developing the scale items, we considered previous research and theory on anxiety symptoms and symptoms reported by clinically referred cases in the Philippines. The scale was validated in a Filipino sample (N = 925). Exploratory factor analysis indicated two factors corresponding to somatic and non-somatic symptoms; confirmatory factor analysis showed good fit for the two-factor model. CPAS-11 showed good internal consistency, convergent and divergent validity, and screening accuracy. A cutoff score of 15 showed adequate sensitivity and specificity to distinguish GAD-7 screened participants. The results support the viability of CPAS-11 as a screening tool to identify individuals experiencing COVID-19-related anxiety.
KW - Anxiety
KW - Coronavirus
KW - COVID-19
KW - Mental health screening
KW - Pandemic
UR - http://www.scopus.com/inward/record.url?scp=85096025782&partnerID=8YFLogxK
UR - https://publons.com/wos-op/publon/35301216/
U2 - 10.1007/s12144-020-01193-2
DO - 10.1007/s12144-020-01193-2
M3 - Journal article
SN - 1046-1310
VL - 41
SP - 5703
EP - 5711
JO - Current Psychology
JF - Current Psychology
IS - 8
ER -
